Literature DB >> 15999153

Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma.

Peter Simsa1, Jean-Luc Teillaud, David I Stott, József Tóth, Beatrix Kotlan.   

Abstract

A major focus of tumor immunology is to reveal the potential role and capacity of immunocompetent cells found in different solid tumor tissues. The most abundant infiltrating cells (TIL), the T lymphocytes have been investigated in details concerning T-cell receptor usage and specificity. However, B cells have hardly been investigated in this respect, although high cellular B-cell infiltration has been correlated with improved patients' survival in some breast carcinomas. This led to our objectives to study variable region gene usage of the tumor-infiltrating B cells in different breast carcinoma types. By defining the immunoglobulin repertoire of the tumor-infiltrating B lymphocytes in the most common invasive ductal carcinoma (IDC) of the breast we compared it to the rare medullary breast carcinoma (MBC). After phenotyping infiltrating ductal carcinomas, B cells were obtained from tumor tissue by microdissection technique. Numerous rearranged TIL-B immunoglobulin heavy chain V genes (VH) were amplified, cloned, sequenced, and comparatively analyzed. Some characteristics were found for both breast carcinoma types. The immunoglobulins produced by TIL-B in ductal carcinoma are highly matured and oligoclonal. We conclude that Ig variable region gene usage reveals similar and distinguishable characteristics of TIL-B immunoglobulin repertoires, which are representative of the nature of the immune responses in invasive ductal and medullary breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15999153     DOI: 10.1007/BF02893374

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  28 in total

1.  Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes.

Authors:  Beatrix Kotlan; Peter Simsa; Jean-Luc Teillaud; Wolf Herman Fridman; Jozsef Toth; Michael McKnight; Mark C Glassy
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

2.  Patterns of human tumor-infiltrating lymphocytes in 120 human cancers.

Authors:  C M Balch; L B Riley; Y J Bae; M A Salmeron; C D Platsoucas; A von Eschenbach; K Itoh
Journal:  Arch Surg       Date:  1990-02

3.  Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion.

Authors:  D J Schwartzentruber; D Solomon; S A Rosenberg; S L Topalian
Journal:  J Immunother (1991)       Date:  1992-07

Review 4.  The immunology and immunotherapy of breast cancer: an update.

Authors:  J W Hadden
Journal:  Int J Immunopharmacol       Date:  1999-02

5.  Immunoglobulin variable regions usage by B-lymphocytes infiltrating a human breast medullary carcinoma.

Authors:  B Kotlan; N Gruel; B Zafrani; G Füredi; J Foldi; G G Petranyi; W H Fridman; J L Teillaud
Journal:  Immunol Lett       Date:  1999-02       Impact factor: 3.685

6.  The role of lymphocytes and macrophages in human breast tumorigenesis: an immunohistochemical and morphometric study.

Authors:  Herzl Ben-Hur; Ophir Cohen; David Schneider; Pavel Gurevich; Reuvit Halperin; Uri Bala; Marta Mozes; Itshak Zusman
Journal:  Anticancer Res       Date:  2002 Mar-Apr       Impact factor: 2.480

Review 7.  [Function and prognostic significance of immune cells infiltrating human tumors].

Authors:  Andrea Ladányi
Journal:  Magy Onkol       Date:  2004-04-23

8.  Maturation of the immune response in germinal centers.

Authors:  C Berek; A Berger; M Apel
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

9.  Immunoglobulin repertoire of B lymphocytes infiltrating breast medullary carcinoma.

Authors:  B Kotlan; P Simsa; J Foldi; W H Fridman; M Glassy; M McKnight; J L Teillaud
Journal:  Hum Antibodies       Date:  2003

10.  Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.

Authors:  P Whitford; E A Mallon; W D George; A M Campbell
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

View more
  9 in total

Review 1.  B lymphocytes and cancer: a love-hate relationship.

Authors:  Grace J Yuen; Ezana Demissie; Shiv Pillai
Journal:  Trends Cancer       Date:  2016-12

2.  Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma.

Authors:  Fei Wang; Juan Bi; Chunxia Yi; Yuan Zhang; Yu Zhang; Qingfang Yue
Journal:  Contrast Media Mol Imaging       Date:  2022-05-19       Impact factor: 3.009

3.  Tumor-infiltrating B cells come into vogue.

Authors:  Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

4.  Identification of novel tumor antigens with patient-derived immune-selected antibodies.

Authors:  Daniel Rodriguez-Pinto; Jason Sparkowski; Martin P Keough; Kathryn N Phoenix; Frank Vumbaca; David K Han; Eckart D Gundelfinger; Philip Beesley; Kevin P Claffey
Journal:  Cancer Immunol Immunother       Date:  2008-06-21       Impact factor: 6.968

5.  The immune microenvironment of human tumors: general significance and clinical impact.

Authors:  Wolf-Herman Fridman; Marie-Caroline Dieu-Nosjean; Franck Pagès; Isabelle Cremer; Diane Damotte; Catherine Sautès-Fridman; Jérôme Galon
Journal:  Cancer Microenviron       Date:  2012-10-30

6.  Challenging tumour immunological techniques that help to track cancer stem cells in malignant melanomas and other solid tumours.

Authors:  Beatrix Kotlan; Vanda Plotar; Klara Eles; Szabolcs Horvath; Timea Balatoni; Orsolya Csuka; Mihaly Újhelyi; Ákos Sávolt; Andras Szollar; Istvan Vamosi-Nagy; Laszlo Toth; Emil Farkas; Jozsef Toth; Miklos Kasler; Gabriella Liszkay
Journal:  Contemp Oncol (Pozn)       Date:  2018-03-05

Review 7.  Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.

Authors:  Claire Germain; Sacha Gnjatic; Marie-Caroline Dieu-Nosjean
Journal:  Front Immunol       Date:  2015-02-23       Impact factor: 7.561

Review 8.  Harnessing the immune system in the battle against breast cancer.

Authors:  Elizabeth S Nakasone; Sara A Hurvitz; Kelly E McCann
Journal:  Drugs Context       Date:  2018-02-12

9.  Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma.

Authors:  Linzhi Han; Hongjie Shi; Yuan Luo; Wenjie Sun; Shuying Li; Nannan Zhang; Xueping Jiang; Yan Gong; Conghua Xie
Journal:  Cancer Med       Date:  2020-10-24       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.